Literature DB >> 5420625

Propranolol in tetralogy of Fallot.

G R Cumming.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5420625     DOI： 10.1161/01.cir.41.1.13

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.

Authors:  C D Furberg
Journal:  Drugs       Date:  1974       Impact factor: 9.546

2.  Determination of infundibular innervation and amine receptor content in cyanotic and acyanotic myocardium: relation to clinical events in tetralogy of Fallot.

Authors:  L B McGrath; C Chen; J Gu; J Bianchi; J M Levett
Journal:  Pediatr Cardiol       Date:  1991-07       Impact factor: 1.655

3.  Propranolol treatment in children with tetralogy of Fallot alters the response to isoprenaline after surgical repair.

Authors:  C Barazzone; C Jaccard; M Berner; P Dayer; J C Rouge; I Oberhansli; B Friedli
Journal:  Br Heart J       Date:  1988-08

Review 4.  Uses of beta-adrenoceptor blocking drugs.

Authors:  B N Prichard; D G McDevitt; R G Shanks
Journal:  J R Coll Physicians Lond       Date:  1976-10

5.  Design and rationale of a clinical trial to increase cardiomyocyte division in infants with tetralogy of Fallot.

Authors:  Samar R El Khoudary; Anthony Fabio; Jessie W Yester; Matthew L Steinhauser; Adam B Christopher; Frank Gyngard; Phillip S Adams; Victor O Morell; Melita Viegas; Jose P Da Silva; Luciana F Da Silva; Mario Castro-Medina; Andrew McCormick; Miguel Reyes-Múgica; Michelle Barlas; Honghai Liu; Dawn Thomas; Niyatie Ammanamanchi; Rachel Sada; Megan Cuda; Elizabeth Hartigan; David K Groscost; Bernhard Kühn
Journal:  Int J Cardiol       Date:  2021-07-12       Impact factor: 4.164
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.